Global Sarcopenia Treatment Market Size To Exceed USD 5.50 Billion By 2035 | CAGR Of 5.23%
Category: HealthcareGlobal Sarcopenia Treatment Market Size To Exceed USD 5.50 Billion By 2035
According to a research report published by Spherical Insights & Consulting, The Global Sarcopenia Treatment Market Size is expected to Grow from USD 3.14 Billion in 2024 to USD 5.50 Billion by 2035, at a CAGR of 5.23% during the forecast period 2025-2035.
Get more details on this report -
Browse key industry insights spread across 200 pages with 100 Market data tables and figures & charts from the report on the “Global Sarcopenia Treatment Market Size, Share, and COVID-19 Impact Analysis, By Treatment Type (Nutritional Supplementation, Physical Therapy, Medications, and Hormonal Therapy), By End User (Hospitals, Clinics, and Homecare Settings), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2025 – 2035.” Get Detailed Report Description Here: https://www.sphericalinsights.com/reports/sarcopenia-treatment-market
The sarcopenia treatment market is the worldwide market for products, treatments, and programs intended to prevent, treat, or reverse sarcopenia, a degenerative skeletal muscle disorder associated with aging and a decline in physical activity. This market includes physical rehabilitation programs, dietary supplements, and pharmaceutical therapies aimed at increasing the muscle mass, strength, and functionality of those who are affected. The market also includes research institutes, pharmaceutical companies, and healthcare providers that collaborate to create and provide effective treatment choices for sarcopenia in a range of demographic groups. Rising per capita healthcare expenses, along with an increase in vitamin insufficiency and malnutrition in developing countries, are expected to fuel the need for sarcopenia therapy supplements. An increase in sarcopenia patients is anticipated to fuel growth in the market for sarcopenia treatments. This growing awareness, which is closely linked to increased investment in sarcopenia treatments and research initiatives, is driving the market. Government programs that encourage healthy aging and the significance of preserving muscle mass are also propelling market growth. However, a lack of awareness and the high cost of protein supplements are predicted to restrict sarcopenia treatment market expansion.
The nutritional supplementation segment dominated the market in 2024 and is projected to grow at a substantial CAGR during the forecast period.
Based on the treatment type, the sarcopenia treatment market is divided into nutritional supplementation, physical therapy, medications, and hormonal therapy. Among these, the nutritional supplementation segment dominated the market in 2024 and is projected to grow at a substantial CAGR during the forecast period. The nutritional supplementation market as the importance of diet in maintaining muscle mass is becoming more well acknowledged.
The hospitals segment accounted for the largest share in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period.
Based on the end user, the sarcopenia treatment market is divided into hospitals, clinics, and homecare settings. Among these, the hospitals segment accounted for the largest share in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period. The hospital segment's large customer base, rising healthcare costs, rising disease rates, and the existence of supportive regulatory frameworks are the main reasons predicting market expansion.
North America is expected to hold the majority share of the global sarcopenia treatment market during the forecast period.
Get more details on this report -
North America is expected to hold the majority share of the global sarcopenia treatment market during the forecast period. The North American region has several benefits, including a robust healthcare system, a high rate of age-related muscle degeneration, and increased awareness of early diagnosis and treatment options.
Asia Pacific is anticipated to grow at the fastest pace in the global sarcopenia treatment market during the forecast period. The market is developing due to advancements in healthcare infrastructure, rising healthcare spending, and the increasing use of cutting-edge medical treatments.
Major vendors in the global sarcopenia treatment market are PFIZER INC., Bayer AG, Novartis AG, NESTLÉ S.A., SANOFI INC., GlaxoSmithKline plc, Zydus Cadilla, Ltd, American Way Corporation, F. HOFFMANN-LA ROCHE LTD, ABBOTT LABORATORIES, INC, and Others.
Key Target Audience
- Market Players
- Investors
- End-users
- Government Authorities
- Consulting and Research Firm
- Venture capitalists
- Value-Added Resellers (VARs)
Recent Development
- In March 2025, Johns Hopkins University granted a patent for technology to Allosteric Bioscience, Inc. (ABI) for the treatment or prevention of sarcopenia, a serious medical condition that involves the loss of muscle mass, quality, and strength and is a major aspect of the natural aging process. Falls, bone fractures, and disability are some of the ways that sarcopenia can lower quality of life.
Market Segment
This study forecasts revenue at global, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the sarcopenia treatment market based on the below-mentioned segments:
Global Sarcopenia Treatment Market, By Treatment Type
- Nutritional Supplementation
- Physical Therapy
- Medications
- Hormonal Therapy
Global Sarcopenia Treatment Market, By End User
- Hospitals
- Clinics
- Homecare Settings
Global Sarcopenia Treatment Market, By Regional Analysis
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia Pacific
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- UAE
- Saudi Arabia
- Qatar
- South Africa
- Rest of the Middle East & Africa
About the Spherical Insights & Consulting
Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.
Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements.
CONTACT US:
For More Information on Your Target Market, Please Contact Us Below:
Phone: +1 303 800 4326 (the U.S.)
Phone: +91 90289 24100 (APAC)
Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com
Contact Us: https://www.sphericalinsights.com/contact-us
Need help to buy this report?